Article Text

Download PDFPDF
Concise report
Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis
  1. Benjamin A Fisher1,
  2. Darren Plant2,
  3. Monica Brode3,
  4. Ronald F van Vollenhoven4,
  5. Linda Mathsson3,
  6. Deborah Symmons2,
  7. Karin Lundberg4,
  8. Johan Rönnelid3,
  9. Patrick J Venables1
  1. 1Kennedy Institute of Rheumatology, Imperial College London, UK
  2. 2Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, UK
  3. 3Unit of Clinical Immunology, Uppsala University and Uppsala University Hospital Uppsala, Sweden
  4. 4 Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden
  1. Correspondence to Dr Benjamin Fisher, Department of Rheumatology, Charing Cross Hospital, Fulham Palace Road, London; benjamin.fisher{at}imperial.ac.uk

Footnotes

  • JR and PJV contributed equally to this work and are joint senior authors.

  • Funding Arthritis Research UK, the Swedish Rheumatism Association and the Swedish Research Council. This study is part of the EU funded research project Autocure, within the 6th Framework Programme.

  • Competing interests A patent for the diagnostic use of the CEP-1 peptide (patent application number: WO0890360, published on 31 July 2008) is jointly held by two of the authors (PJV and KL) and funded by Imperial Innovations, Imperial College London.

  • Ethics approval This study was conducted with the approval of the Norwich research ethics committee and Northern Stockholm ethical committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • JR and PJV contributed equally to this work and are joint senior authors.

  • Funding Arthritis Research UK, the Swedish Rheumatism Association and the Swedish Research Council. This study is part of the EU funded research project Autocure, within the 6th Framework Programme.

  • Competing interests A patent for the diagnostic use of the CEP-1 peptide (patent application number: WO0890360, published on 31 July 2008) is jointly held by two of the authors (PJV and KL) and funded by Imperial Innovations, Imperial College London.

  • Ethics approval This study was conducted with the approval of the Norwich research ethics committee and Northern Stockholm ethical committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.